Atrium Therapeutics Presents Preclinical Data on ATR1072 Cardiac Function
Atrium Therapeutics presented preclinical data showing ATR1072 normalizes key cardiac function measures.
Related stories
Boliden Q3 Revenue Beats on Record Kevitsa Milled Volume
M impact | EQUITY | Oct 29, 2026, 12:18 PM UTC
Microsoft Reportedly Plans U.S. Bond Issuance
Reuters reports, citing Bloomberg News and people familiar with the matter, that Microsoft plans to issue bonds in the United States.
M impact | EQUITY | Oct 29, 2026, 12:18 PM UTC
Mastercard Beats Q3 Revenue and Adjusted EPS Estimates
M impact | EQUITY | Oct 29, 2026, 12:18 PM UTC
West Pharma Executive Says Q3 Cyber-Deferred Revenue Fully Recovered
A West Pharma executive said revenue deferred by a cyber incident in Q3 was fully recovered.
M impact | EQUITY | Oct 29, 2026, 12:17 PM UTC
Microsoft to Raise $25 Billion in U.S. Bond Sale, Bloomberg Reports
Bloomberg News reports that Microsoft plans to raise $25 billion through a U.S. bond sale.
M impact | EQUITY | Oct 29, 2026, 12:17 PM UTC
Anker Innovations Reports Third-Quarter Net Profit Down 27% Year Over Year
M impact | EQUITY | Oct 29, 2026, 12:17 PM UTC